Good morning :)
Place Order
Add to Watchlist

Sunil Healthcare Ltd

SUNLOC

Sunil Healthcare Ltd

SUNLOC
Health CarePharmaceuticals
SmallcapWith a market cap of ₹85 cr, stock is ranked 3,137
High RiskStock is 3.92x as volatile as Nifty
83.002.92% (-2.50)
83.002.92% (-2.50)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹85 cr, stock is ranked 3,137
High RiskStock is 3.92x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹85 cr, stock is ranked 3,137
High RiskStock is 3.92x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-47.021.22
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.276.550.51%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Sunil Healthcare Limited is engaged in manufacturing hard gelatin capsule shells and food products. The Company is engaged in market survey and supply chain establishment by markets its products under the Sunloc Foods brand name.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 3.31%, vs industry avg of 9.03%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.04% to 0.03%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue109.8593.5681.0684.7096.20120.84114.9995.4193.35
Raw Materialssubtract49.4536.6435.0035.4832.7143.3050.0146.9883.70
Power & Fuel Costsubtract6.878.899.539.278.398.909.359.04
Employee Costsubtract10.6712.5712.5713.0212.3014.2514.7913.06
Selling & Administrative Expensessubtract7.027.988.058.028.6411.8110.026.50
Operating & Other expensessubtract19.4411.364.4611.4323.2923.5210.1510.52
Depreciation/Amortizationsubtract4.334.785.746.136.116.317.016.095.95
Interest & Other Itemssubtract4.185.036.586.955.313.494.175.786.02
Taxes & Other Itemssubtract2.861.81-0.18-0.630.092.842.80-0.77-0.51
EPS4.914.39-0.67-4.85-0.626.266.52-1.75-1.77
DPS0.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2016

Annual Report Unavailable

Investor Presentation

May 31PDF
Mar 1PDF
FY 2017

Annual Report Unavailable

Investor Presentation

Feb 14PDF
Nov 12PDF
Aug 12PDF
FY 2018

Annual Report Unavailable

Investor Presentation

May 28PDF
Dec 5PDF
Aug 24PDF
FY 2019

Annual Report Unavailable

Investor Presentation

Nov 12PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Sunil Healthcare Ltd-47.551.22
Sun Pharmaceutical Industries Ltd45.346.470.75%
Cipla Ltd31.214.800.82%
Torrent Pharmaceuticals Ltd65.3815.800.88%

Price Comparison

Compare SUNLOC with any stock or ETF
Compare SUNLOC with any stock or ETF
SUNLOC
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding73.53%0.00%0.10%0.00%26.37%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

SUNLOC has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Corporate
Sunil Healthcare to announce Quarterly Result

Sunil Healthcare will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Sunil Healthcare to conduct AGM

Sunil Healthcare announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Sunil Healthcare to conduct AGM

Sunil Healthcare announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Sunil Healthcare reports consolidated net loss of Rs 0.69 crore in the June 2024 quarter

Net Loss of Sunil Healthcare reported to Rs 0.69 crore in the quarter ended June 2024 as against net loss of Rs 0.64 crore during the previous quarter ended June 2023. Sales declined 4.49% to Rs 21.50 crore in the quarter ended June 2024 as against Rs 22.51 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales21.5022.51 -4 OPM %10.283.64 - PBDT0.840.74 14 PBT-0.65-0.87 25 NP-0.69-0.64 -8 Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Sunil Healthcare to table results

Sunil Healthcare will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live